- Home
- RGNX vs ADSE Comparison
RGNX vs ADSE Comparison
Compare RGNX & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | ADSE |
|---|---|---|
| Founded | 2008 | 1980 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 900.0M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RGNX | ADSE |
|---|---|---|
| Price | $7.45 | $9.49 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $23.58 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 39.7K |
| Earning Date | 11-09-2026 | 10-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | N/A | $1,305.94 |
| Revenue Next Year | $23.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $8.51 |
| 52 Week High | $16.19 | $13.50 |
Technical Indicators
Market Signals| Indicator | RGNX | ADSE |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 39.17 |
| Support Level | $6.96 | N/A |
| Resistance Level | $8.31 | $12.07 |
| Average True Range (ATR) | 0.43 | 0.64 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 55.77 | 46.07 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. The company generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.